SCHEMBL14928834

SCHEMBL14928834

CCC[C@H](CC)Nc1nc(Cl)c(C#N)cc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KHK P50053 1/20 0.44
PGK1 P00558 1/20 0.35
CRHR1 P34998 5/20 0.35
POLB P06746 1/20 0.34
ALDH1A1 P00352 1/20 0.33
SOS1 Q07889 1/20 0.33
PKM P14618 1/20 0.33
KCNH2 Q12809 3/20 0.32
CYP2D6 P10635 2/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
NOS2 P35228 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
JAK2 O60674 2/20 0.32
JAK3 P52333 2/20 0.32
LIMK1 P53667 1/20 0.32
LIMK2 P53671 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14928839 0.93 KHK (0.43) KHKPGK1CRHR1POLBALDH1A1
SCHEMBL3387733 0.90 KHK (0.46) KHKPGK1POLBALDH1A1PKM
SCHEMBL14909396 0.90 KHK (0.46) KHKPGK1POLBALDH1A1PKM
SCHEMBL14928413 0.89 KHK (0.42) KHKPGK1CRHR1POLBALDH1A1
SCHEMBL14928623 0.86 KHK (0.43) KHKPGK1CRHR1ALDH1A1SOS1
SCHEMBL14928858 0.86 KHK (0.43) KHKPGK1CRHR1ALDH1A1SOS1
SCHEMBL14928808 0.84 KHK (0.42) KHKPGK1POLBALDH1A1PKM
SCHEMBL14928686 0.84 KHK (0.43) KHKPGK1POLBALDH1A1PKM
SCHEMBL3346566 0.83 KHK (0.44) KHKPGK1POLBALDH1A1PKM
SCHEMBL3380252 0.83 KHK (0.44) KHKPGK1POLBALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895585-B2 Nicotinamide derivative or salt thereof FUJIFILM CORPORATION (JP) 2014-11-25 US disclosed
US-8809371-B2 2014-08-19 US disclosed
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF FUJIFILM CORPORATION (JP) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116430-A1 NOVEL NICOTINAMIDE DERIVATIVE OR SALT THEREOF SYK, CD38, BTK KHK 2008/4885PGK1 4462/4885CRHR1 2628/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.